Commercialisation

X

Project goal

  • To support this start-up company from CE mark through clinical studies and commercialization

Metrics for success

  • Key opinion leader endorsement & first commercial sales in France

Results

  • TearLab seen as the standard of care for objectively diagnosing dry eye disease

Project goal

  • EU Market Assessment, development of EU commercial model & initial commercial rollout

Metrics for success

  • Commercial model and first EU sales

Results

  • Commercial model established in 2012. First sales in 2013-2014. Company bought by Alcon in Oct 2014

Project goal

  • Initial European commercial introduction starting with a 4-site seeding study in UK, Germany, France & Belgium

Metrics for success

  • Beta sites able to recruit and convert patients + long-term usage of system

Results

  • Fifty percent of the sites have fully integrated TearScience into their practices. TearScience has now been aquired by Johnson & Johnson

Project goal

  • Establishment of the European commercial business

Metrics for success

  • Distributors signed in Germany, France, UK & Spain

Results

  • First distribution contracts to be signed in Q4 2017